MicroTech Medical (Hangzhou) Co., Ltd.の主要な財務諸表は何ですか?
02235.HKの主要な財務比率は何ですか?
MicroTech Medical (Hangzhou) Co., Ltd.の収益はセグメントまたは地域別にどのように分けられていますか?
MicroTech Medical (Hangzhou) Co., Ltd.は収益を上げていますか?
MicroTech Medical (Hangzhou) Co., Ltd.に負債はありますか?
MicroTech Medical (Hangzhou) Co., Ltd.の発行済株式数は何株ですか?
主要データ
前終値
$7.78
始値
$7.78
当日レンジ
$7.75 - $7.8
52週レンジ
$4 - $9.17
取引高
44.5K
平均取引高
239.8K
1株当たり利益(TTM)
-0.07
配当利回り
--
時価総額
$1.2B
MICROTECH MED-Bとは何ですか?
MicroTech Medical (Hangzhou) Co., Ltd. engages in the research and development, manufacture, and commercialization of diabetes management medical devices and consumables. The company is headquartered in Hangzhou, Zhejiang and currently employs 645 full-time employees. The company went IPO on 2021-10-19. The firm's main business is engaged in the manufacture and sale of blood glucose monitoring system (BGMS), continuous glucose monitoring system (CGMS) and insulin pump systems. The firm has the portfolio of products in the field of diabetes monitoring, treatment and management, covering patch insulin pump system, CGMS, closed-loop artificial pancreas system, BGMS products, as well as diabetes digital management software. The firm conducts its businesses in the domestic and overseas markets.